[go: up one dir, main page]

MX2008001213A - Formulacion farmaceutica de derivados nitrooxi de farmacos anti-inflamatorios no esteroidales. - Google Patents

Formulacion farmaceutica de derivados nitrooxi de farmacos anti-inflamatorios no esteroidales.

Info

Publication number
MX2008001213A
MX2008001213A MX2008001213A MX2008001213A MX2008001213A MX 2008001213 A MX2008001213 A MX 2008001213A MX 2008001213 A MX2008001213 A MX 2008001213A MX 2008001213 A MX2008001213 A MX 2008001213A MX 2008001213 A MX2008001213 A MX 2008001213A
Authority
MX
Mexico
Prior art keywords
sub
pharmaceutical formulation
nitrooxyderivatives
nsaids
formula
Prior art date
Application number
MX2008001213A
Other languages
English (en)
Inventor
Christina Holmberg
Ulla Gasslander
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Publication of MX2008001213A publication Critical patent/MX2008001213A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invencion se refiere a una formulacion farmaceutica que comprende: a) uno o mas de los NSAID de liberacion de NO de formula (I); (ver formula) b) uno o mas agentes tensioactivos; c) un compuesto depurador de carbonilo seleccionado de formas de acido libre, sales, derivados de ester de acido carboxilico de un compuesto de formula (II): (H2N-(CH2)m-(C6H4)-COOH (II)) en donde m = 0-10, y d) opcionalmente un aceite o grasa semi-solida y/o un alcohol de cadena corta.
MX2008001213A 2005-07-26 2006-06-29 Formulacion farmaceutica de derivados nitrooxi de farmacos anti-inflamatorios no esteroidales. MX2008001213A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05106854 2005-07-26
PCT/EP2006/063672 WO2007012539A2 (en) 2005-07-26 2006-06-29 Pharmaceutical formulation of nitrooxyderivatives of nsaids

Publications (1)

Publication Number Publication Date
MX2008001213A true MX2008001213A (es) 2008-03-24

Family

ID=37670077

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001213A MX2008001213A (es) 2005-07-26 2006-06-29 Formulacion farmaceutica de derivados nitrooxi de farmacos anti-inflamatorios no esteroidales.

Country Status (24)

Country Link
US (1) US8691869B2 (es)
EP (1) EP1906938B1 (es)
JP (1) JP5238499B2 (es)
KR (1) KR101342910B1 (es)
CN (1) CN101227896B (es)
AR (1) AR055094A1 (es)
AT (1) ATE485033T1 (es)
AU (1) AU2006274098B2 (es)
CA (1) CA2616508C (es)
CY (1) CY1112023T1 (es)
DE (1) DE602006017701D1 (es)
DK (1) DK1906938T3 (es)
ES (1) ES2354278T3 (es)
HR (1) HRP20110025T1 (es)
IL (1) IL188253A0 (es)
MX (1) MX2008001213A (es)
NO (1) NO20080983L (es)
NZ (1) NZ564589A (es)
PL (1) PL1906938T3 (es)
PT (1) PT1906938E (es)
RU (1) RU2406482C2 (es)
SI (1) SI1906938T1 (es)
WO (1) WO2007012539A2 (es)
ZA (1) ZA200801009B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011209757A (ja) * 2011-07-06 2011-10-20 Rohto Pharmaceutical Co Ltd コンタクトレンズケア方法及び組成物
US9688607B2 (en) * 2011-08-15 2017-06-27 Research Foundation Of The City University Of New York No- and H2S-releasing compounds
WO2013130625A1 (en) * 2012-02-27 2013-09-06 Basil Rigas Phospho-ester derivatives and uses thereof
RU2657803C1 (ru) * 2017-03-21 2018-06-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный университет" Средство, обладающее противовоспалительным и анальгезирующим действием

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033568A1 (en) * 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
AU2003240536B2 (en) * 2002-06-05 2007-11-15 Ivax Pharmaceuticals, S.R.O. Reduction of gelatin cross-linking
BR0313149A (pt) 2002-07-31 2005-06-28 Pharmacia Corp Forma de dosagem farmacêutica capaz de manter estável o perfil de dissolução após armazenamento

Also Published As

Publication number Publication date
CN101227896B (zh) 2013-02-06
KR101342910B1 (ko) 2013-12-19
RU2406482C2 (ru) 2010-12-20
CN101227896A (zh) 2008-07-23
CA2616508A1 (en) 2007-02-01
ATE485033T1 (de) 2010-11-15
NZ564589A (en) 2010-01-29
HK1120414A1 (en) 2009-04-03
US8691869B2 (en) 2014-04-08
ES2354278T3 (es) 2011-03-11
JP5238499B2 (ja) 2013-07-17
IL188253A0 (en) 2008-04-13
HRP20110025T1 (hr) 2011-03-31
WO2007012539A3 (en) 2007-04-19
AU2006274098A1 (en) 2007-02-01
ZA200801009B (en) 2008-11-26
JP2009502850A (ja) 2009-01-29
PL1906938T3 (pl) 2011-05-31
US20090203759A1 (en) 2009-08-13
EP1906938B1 (en) 2010-10-20
AU2006274098B2 (en) 2012-02-09
DE602006017701D1 (de) 2010-12-02
CY1112023T1 (el) 2015-11-04
PT1906938E (pt) 2011-01-17
AR055094A1 (es) 2007-08-08
DK1906938T3 (da) 2011-02-07
CA2616508C (en) 2015-02-24
RU2008104505A (ru) 2009-09-10
WO2007012539A2 (en) 2007-02-01
SI1906938T1 (sl) 2011-02-28
EP1906938A2 (en) 2008-04-09
NO20080983L (no) 2008-02-25
KR20080028412A (ko) 2008-03-31

Similar Documents

Publication Publication Date Title
EA201100005A1 (ru) Гербицидные композиции, содержащие 4-амино-3,6-дихлорпиридин-2-карбоновую кислоту
AR064842A1 (es) Pirrolidin-2-onas, y su uso en la preparacion de inhibidores de nep
HRP20120323T1 (en) Diarylhydantoin compounds
CY1113011T1 (el) Νεα κρυσταλλικη μορφη v της αγομελατινης, μεθοδος παρασκευης αυτης και φαρμακευτικες συνθεσεις που περιεχουν αυτην
UA108645C2 (uk) Композиція для боротьби з хворобами рослин і її застосування
EA200970124A1 (ru) Производные 2-арилиндола в качестве ингибиторов npges-1
EA200701810A1 (ru) Производное изоксазолина и новый способ его получения
WO2010005572A3 (en) Alpha-keto heterocycles as faah inhibitors
MA32721B1 (fr) Composition pharmaceutique solide
WO2010009829A3 (en) Agricultural compositions
ATE305777T1 (de) Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation
EA200800777A1 (ru) Применение сложных эфиров молочной кислоты для улучшения действия пестицидов
FR2925325B1 (fr) Utilisation d'un hydrolysat de colza en tant que principe actif activateur de la synthese des aquaporines
FR2925332B1 (fr) Utilisation d'un hydrolysat d'epeautre en tant que principe actif activateur de la synthese des aquaporines
WO2007120725A3 (en) Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
BR0112245B1 (pt) Éster de ácido 4-alcóxi-ciclohexano-1-amino-carboxílico
FR2925331B1 (fr) Utilisation d'un hydrolysat de feve en tant que principe actif activateur de la synthese des aquaporines
FR2925329B1 (fr) Utilisation d'un hydrolysat d'avoine en tant que principe actif activateur de la synthese des aquaporines
CO6220854A2 (es) Nuevo procedimiento para la preparacion de 4,4´-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona)
MX2008001213A (es) Formulacion farmaceutica de derivados nitrooxi de farmacos anti-inflamatorios no esteroidales.
EP2053038A4 (en) AMINO ALCOHOL DERIVATIVE AND THESE IMMUNOSUP PRESSIVES CONTAINING ACTIVE INGREDIENTS
AR057909A1 (es) Proceso para preparar montelukast y compuestos relacionados, que utiliza un compuesto intermediario derivado de un ester sulfonico.
AR060155A1 (es) Combinaciones de principios activos con propiedades insecticidas y acaricidas
UA94955C2 (en) Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
EA201101014A1 (ru) Сульфонамиды, предназначенные для лечения респираторных нарушений

Legal Events

Date Code Title Description
FG Grant or registration